A study of Immunotherapy for Advanced Renal Cell Carcinoma

What we are studying

A research study of an experimental (investigational) drug AGS-003 to see if it is effective against kidney cancer.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosis or clinical signs of advanced Renal Cell Carcinoma Scheduled for cytoreductive or partial nephrectomy

What is involved

  • A number of clinic visits including screenings
  • Treatment and follow-ups.

Compensation

To help cover the costs of participating in this study, subjects will be paid $50 travel reimbursement for their participation.

Contact Information

Study Coordinator
Christie Cunningham
Email
ccunning@wakehealth.edu
Phone
336-713-9072

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.